Colleen Hall

Oct 15, 2024 | oncpracticemanagement.com | Dawn Holcombe |Colleen Hall |Makema Massey |PMI-Approved Instructor

Subscribe Today! To sign up for our free e-Newsletter or print publications, please enter your contact information below.

Aug 20, 2024 | oncpracticemanagement.com | Colleen Hall

BOSTON—With specialty medicine comprising about half of all drug spending on the market in the United States today, the concept of getting necessary prescriptions in the hands of patients with life-threatening illnesses can, at times, seem daunting for providers, patients, and policymakers alike.1 Fortunately, a panel discussion held here at the 6th Annual NCODA Oncology Institute offered some tips for those in attendance to help them do just that, taking a comprehensive look at the process...

Jun 26, 2024 | theoncologypharmacist.com | Meg Barbor |Charlie Dawson |Colleen Hall

BOSTON—Imagine a circle, with healthcare providers, researchers, and community partners such as churches making up the outer ring. In the center, picture a patient with cancer. All of those groups working together is the key to boosting clinical trial engagement, particularly in underrepresented populations, according to a panel of speakers at NCODA’s 6th Annual Oncology Institute meeting held in Boston in August.

Jun 26, 2024 | oncpracticemanagement.com | Patricia A. Stewart |Meg Barbor |Colleen Hall

BOSTON—Imagine a circle, with health care providers, researchers, and community partners such as churches making up the outer ring. In the center, picture a patient with cancer. All of those groups working together is the key to boosting clinical trial engagement, particularly in underrepresented populations, according to a panel of speakers at NCODA’s 6th Annual Oncology Institute meeting held here this week.

Jun 26, 2024 | oncpracticemanagement.com | Colleen Hall

BOSTON—Imagine a circle, with health care providers, researchers, and community partners such as churches making up the outer ring. In the center, picture a patient with cancer. All of those groups working together is the key to boosting clinical trial engagement, particularly in underrepresented populations, according to a panel of speakers at NCODA’s 6th Annual Oncology Institute meeting held here this week.